Cleared Traditional

K915174 - JMS APHERESIS NEEDLE

K915174 is an FDA 510(k) clearance for JMS APHERESIS NEEDLE, manufactured by Jms Co., Ltd.. The device is a Class 2 Gastroenterology & Urology device with product code FIE cleared through the Traditional 510(k) pathway after a 473-day FDA review.

K915174 · Jms Co., Ltd. · Gastroenterology & Urology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Mar 1993
Decision
473d
Days
Class 2
Risk

K915174 is an FDA 510(k) clearance for the JMS APHERESIS NEEDLE. Classified as Needle, Fistula (product code FIE), Class II - Special Controls.

Submitted by Jms Co., Ltd. (Hiroshima, JP). The FDA issued a Cleared decision on March 2, 1993 after a review of 473 days - an unusually long review period, suggesting complex equivalence evaluation.

This device falls under the Gastroenterology & Urology FDA review panel, regulated under 21 CFR 876.5540 - the FDA gastroenterology and urology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: High-complexity regulatory submission. Elevated predicate reliance profile. The extended review timeline suggests the FDA required additional documentation before confirming substantial equivalence - a pattern common in complex or first-of-kind Gastroenterology & Urology submissions.

View all Jms Co., Ltd. devices

FDA 510(k) Submission Details - K915174

510(k) Number K915174 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received November 15, 1991
Decision Date March 02, 1993
Days to Decision 473 days
Submission Type Traditional
Review Panel Gastroenterology & Urology (GU)
Summary Statement
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
342d slower than avg
Panel avg: 131d · This submission: 473d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

FIE Device Classification - Class 2, Special Controls

Product Code FIE Needle, Fistula
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 876.5540
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Gastroenterology & Urology devices follow this clearance model.

Regulatory Peers - FIE Needle, Fistula

All 63
Devices cleared under the same product code (FIE) and FDA review panel - the closest regulatory comparables to K915174.
NIPRO ARTERIAL VENOUS FISTULA NEEDLE
K955182 · Nissho Corp. · Jun 1996
BRAUN DIACAN(R) FISTULA NEEDLES
K945850 · B. Braun of America, Inc. · Oct 1995
MEDISYSTEMS APHERESIS NEEDLE WITH GUARD
K932074 · Medisystems Corp. · Feb 1994
JMS AV FISTULA NEEDLES
K911199 · Jms Co., Ltd. · Aug 1991
MEDISYSTEMS HEMODIALYSIS FISTULA SET
K910734 · Medisystems Corp. · Jun 1991
EXEL A-V FISTULA SET
K903945 · Exel Intl. · Nov 1990